BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28745142)

  • 1. Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: Review on the basis of
    Krzysztoforska K; Mirowska-Guzel D; Widy-Tyszkiewicz E
    Nutr Neurosci; 2019 Feb; 22(2):72-82. PubMed ID: 28745142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.
    Ullah R; Khan M; Shah SA; Saeed K; Kim MO
    Nutrients; 2019 May; 11(6):. PubMed ID: 31141884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
    Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
    Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, antioxidants and neurodegenerative diseases.
    Casetta I; Govoni V; Granieri E
    Curr Pharm Des; 2005; 11(16):2033-52. PubMed ID: 15974957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural antioxidants and neurodegenerative diseases.
    Bastianetto S; Quirion R
    Front Biosci; 2004 Sep; 9():3447-52. PubMed ID: 15353369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review.
    Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M
    Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural polyphenols against neurodegenerative disorders: potentials and pitfalls.
    Ebrahimi A; Schluesener H
    Ageing Res Rev; 2012 Apr; 11(2):329-45. PubMed ID: 22336470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases.
    Moretti M; Fraga DB; Rodrigues ALS
    CNS Neurosci Ther; 2017 Dec; 23(12):921-929. PubMed ID: 28980404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anthocyanins for the prevention and treatment of neurodegenerative diseases].
    Katasonov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):16-22. PubMed ID: 35485060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
    Halliwell B
    Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic antioxidants in neurodegenerative diseases.
    Chang KH; Cheng ML; Chiang MC; Chen CM
    Clin Chim Acta; 2018 Oct; 485():79-87. PubMed ID: 29940147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine and neurodegeneration: A review of literature.
    Ahmed T; Gilani AU; Abdollahi M; Daglia M; Nabavi SF; Nabavi SM
    Pharmacol Rep; 2015 Oct; 67(5):970-9. PubMed ID: 26398393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and the pathogenesis of neurodegenerative disorders.
    Reynolds A; Laurie C; Mosley RL; Gendelman HE
    Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants as treatment for neurodegenerative disorders.
    Moosmann B; Behl C
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1407-35. PubMed ID: 12387703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms.
    Masella R; Santangelo C; D'Archivio M; Li Volti G; Giovannini C; Galvano F
    Curr Med Chem; 2012; 19(18):2901-17. PubMed ID: 22519395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.